ACT-293987 in Pulmonary Arterial Hypertension

NCT01112306 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

709

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: ACT-293987

Sponsor

Actelion